Cargando…
Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes
BACKGROUND/AIMS: Allopurinol is a urate-lowering agent that is commonly used to prevent chemotherapy-related hyperuricemia. Allopurinol hypersensitivity syndrome (AHS) is a disorder involving multiple organs, which may be accompanied by cutaneous adverse reactions. We identified the characteristics...
Autores principales: | Min, Hong Ki, Lee, Boin, Kwok, Seung-Ki, Ju, Ji Hyeon, Kim, Wan-Uk, Park, Young Min, Park, Sung-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497340/ https://www.ncbi.nlm.nih.gov/pubmed/26161019 http://dx.doi.org/10.3904/kjim.2015.30.4.521 |
Ejemplares similares
-
248 HLA-B58 Does not Increase Allopurinol Hypersensitivity among Patients with Hematologic Malignancy
por: Jung, Jae-Woo, et al.
Publicado: (2012) -
Allopurinol hypersensitivity syndrome
por: Yaseen, Wid, et al.
Publicado: (2023) -
Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor
por: Min, Hong Ki, et al.
Publicado: (2019) -
Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
por: Jung, Seung Min, et al.
Publicado: (2019) -
Pustular drug hypersensitivity syndrome due to allopurinol
por: Salem, Chaker Ben, et al.
Publicado: (2015)